Rauno Joks
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rauno Joks has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
Helen G. Durkin
6 shared publications- Jonathan Ian Silverberg
Department of Dermatology, The George Washington University School of Medicine and Health Sciences , Washington, DC
4 shared publications - Tamar Anne Smith-Norowitz
Department of Pediatrics, SUNY Downstate Health Sciences University, Brooklyn, NY 11203, USA
4 shared publications Tamar A. Smith-Norowitz
State Univ New York Downstate Hlth Sci Univ, Dept Pediat, Brooklyn, NY USA
3 shared publicationsBryan McCarthy
2 shared publicationsHelen G Durkin
2 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by MDPI AG in Pediatric Reports
- Vol. 18 (5) , 130
Evaluation of Asthma/Atopic Outcomes in Relation to Breastfeeding Status Among HIV-Exposed Uninfected and HIV-Unexposed Uninfected Children
Objectives: Perinatal Human Immunodeficiency Virus (HIV) exposure may contribute to the development of asthma and atopic diseases through alterations in immune regulation. While an increased prevalence of atopic conditions has been reported among perinatally HIV-infected children, less is known about children who are HIV-exposed but uninfected (HEU). Breastfeeding provides important benefits for infants; until recently, breastfeeding was not recommended in women living with HIV (WLHIV). The focus of this study was the evaluation of asthma/atopic outcomes in relation to breastfeeding history among HEU and HIV-unexposed uninfected (HUU) children. Methods: A retrospective chart review (2005–2026) that examined pediatric medical records of children (M/F, 0–21 y/o) at an academic medical center (Brooklyn, NY) who were either perinatally HEU (N = 67) or HUU (N = 58). Data collected included infant-feeding practices (breast milk exposed or not exposed), demographics, medical and family history, and physician-diagnosed asthma or atopic conditions. Results: A medical diagnosis of atopy or asthma was associated with perinatal HIV exposure across both groups (p = 0.006) (Fisher exact test). HEU and HUU children were either breastfed (N = 13, 54, respectively) or not (N = 54, 4, respectively). However, when comparing exposure to breast milk versus no breast milk exposure, there was no association between perinatal HIV exposure and asthma or atopy in either group (p = 0.31, 0.19, respectively). Conclusions: Among both breast-milk-exposed and non-exposed children, there was no statistically significant difference in asthma/atopy prevalence between HEU and HUU children.
- 29 September 2026
- Published by MDPI AG in Pediatric Reports
- Vol. 18 (5) , 130
Open AccessEvaluation of Asthma/Atopic Outcomes in Relation to Breastfeeding Status Among HIV-Exposed Uninfected and HIV-Unexposed Uninfected Children
Objectives: Perinatal Human Immunodeficiency Virus (HIV) exposure may contribute to the development of asthma and atopic diseases through alterations in immune regulation. While an increased prevalence of atopic conditions has been reported among perinatally HIV-infected children, less is known about children who are HIV-exposed but uninfected (HEU). Breastfeeding provides important benefits for infants; until recently, breastfeeding was not recommended in women living with HIV (WLHIV). The focus of this study was the evaluation of asthma/atopic outcomes in relation to breastfeeding history among HEU and HIV-unexposed uninfected (HUU) children. Methods: A retrospective chart review (2005–2026) that examined pediatric medical records of children (M/F, 0–21 y/o) at an academic medical center (Brooklyn, NY) who were either perinatally HEU (N = 67) or HUU (N = 58). Data collected included infant-feeding practices (breast milk exposed or not exposed), demographics, medical and family history, and physician-diagnosed asthma or atopic conditions. Results: A medical diagnosis of atopy or asthma was associated with perinatal HIV exposure across both groups (p = 0.006) (Fisher exact test). HEU and HUU children were either breastfed (N = 13, 54, respectively) or not (N = 54, 4, respectively). However, when comparing exposure to breast milk versus no breast milk exposure, there was no association between perinatal HIV exposure and asthma or atopy in either group (p = 0.31, 0.19, respectively). Conclusions: Among both breast-milk-exposed and non-exposed children, there was no statistically significant difference in asthma/atopy prevalence between HEU and HUU children.
- Open Access
- 22 June 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (6) , 336
Serum Albumin, Globulin and Albumin–Globulin Ratios as Biomarkers of Clinical Outcomes in COVID-19 Pneumonia
Objective: Low serum albumin has been linked to morbidity and mortality in critically ill patients, including those with COVID-19. Whether serum globulin levels and albumin/globulin ratios (AGRs) can serve as biomarkers in COVID-19 is less well-characterized. This study assessed serum total protein, albumin, globulin levels, and AGR in relation to clinical outcomes in adults hospitalized with COVID-19 pneumonia. Methods: A retrospective EMR analysis was conducted among 569 hospitalized patients with COVID-19 pneumonia identified during the study period, of whom 60 met inclusion criteria of the required clinical immunologic and laboratory data and comprised the final analytic cohort. Variables included demographics and laboratory markers (total protein, albumin, globulin, immunoglobulins, CRP, and IL-6). The study evaluated: (1) Charlson Comorbidity Index (CCI), (2) Charlson 10-Year Estimated Survival (C10YES), (3) clinical severity using the NEWS-2 score, (4) length of hospital stay (LOS), and (5) mortality. Spearman correlations, chi-square tests, and regression analyses were conducted. Results: Albumin was independently associated with CCI, C10YES, and LOS in adjusted models (p = 0.01, p = 0.004, and p < 0.001, respectively), as was AGR (p = 0.012, p = 0.006, and p = 0.024, respectively). Decreasing total protein levels were independently associated with higher NEWS-2 scores, lower C10YES, and longer LOS (p = 0.009, p = 0.042, and p < 0.001, respectively). Increasing age was associated with longer LOS after adjustment for sex and the other plasma proteins. Globulin levels were not associated with clinical outcomes. Conclusions: Lower serum total protein was associated with higher COVID-19 severity, and lower albumin and AGR were associated with greater morbidity, lower predicted survival, and longer LOS. Increasing age was associated with longer LOS. In patients hospitalized with COVID-19 pneumonia, albumin and AGR may serve as potential biomarkers facilitating personalized risk stratification of hospital course and recovery.
- 22 June 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (6) , 336
Open AccessSerum Albumin, Globulin and Albumin–Globulin Ratios as Biomarkers of Clinical Outcomes in COVID-19 Pneumonia
Objective: Low serum albumin has been linked to morbidity and mortality in critically ill patients, including those with COVID-19. Whether serum globulin levels and albumin/globulin ratios (AGRs) can serve as biomarkers in COVID-19 is less well-characterized. This study assessed serum total protein, albumin, globulin levels, and AGR in relation to clinical outcomes in adults hospitalized with COVID-19 pneumonia. Methods: A retrospective EMR analysis was conducted among 569 hospitalized patients with COVID-19 pneumonia identified during the study period, of whom 60 met inclusion criteria of the required clinical immunologic and laboratory data and comprised the final analytic cohort. Variables included demographics and laboratory markers (total protein, albumin, globulin, immunoglobulins, CRP, and IL-6). The study evaluated: (1) Charlson Comorbidity Index (CCI), (2) Charlson 10-Year Estimated Survival (C10YES), (3) clinical severity using the NEWS-2 score, (4) length of hospital stay (LOS), and (5) mortality. Spearman correlations, chi-square tests, and regression analyses were conducted. Results: Albumin was independently associated with CCI, C10YES, and LOS in adjusted models (p = 0.01, p = 0.004, and p < 0.001, respectively), as was AGR (p = 0.012, p = 0.006, and p = 0.024, respectively). Decreasing total protein levels were independently associated with higher NEWS-2 scores, lower C10YES, and longer LOS (p = 0.009, p = 0.042, and p < 0.001, respectively). Increasing age was associated with longer LOS after adjustment for sex and the other plasma proteins. Globulin levels were not associated with clinical outcomes. Conclusions: Lower serum total protein was associated with higher COVID-19 severity, and lower albumin and AGR were associated with greater morbidity, lower predicted survival, and longer LOS. Increasing age was associated with longer LOS. In patients hospitalized with COVID-19 pneumonia, albumin and AGR may serve as potential biomarkers facilitating personalized risk stratification of hospital course and recovery.
- 1 May 2023
- Vol. 53 (3) , 341-352
Serum Immunoglobulin Levels as Potential Biomarkers of COVID-19 Pneumonia
Objective. Severe Acute Respiratory Coronavirus-2 (SARS-CoV-2) has been known to cause immune dysregulation. However, the association between specific immunoglobulins and clinical characteristics in COVID-19 remains poorly understood. This study investigated the relationship between immunoglobulins and clinical outcomes in adults hospitalized with COVID-19 pneumonia. Methods. A retrospective chart analysis was performed (N=569, December 2020-April 2021). Information on demographics, clinical factors, and total serum immunoglobulin (IgG, IgA, IgM, and IgE) levels were collected (N=60). Clinical outcomes of interest included: symptom duration, comorbidities (Charlson 10-year-estimated-survival (C10YES) and comorbidity index (CCI), vital derangements upon presentation (NEWS-2-score), length of stay (LOS), and mortality. Spearman correlation, chi-square tests and linear regression were conducted. Results. Serum IgM levels were positive predictors of C10YES (beta=0.104, p=0.023) and negative predictors of CCI (beta=-0.007, p=0.047). There was an association between higher serum IgG levels and longer LoS (beta=7.455, p=0.047). We found no significant associations between immunoglobulins and pre-admission symptom duration, medication use, or mortality. Conclusions. Total IgM was associated with increased survival and decreased comorbidity, and total IgG was associated with length of hospitalization. IgM may predict the body's initial ability to produce humoral immune responses, and IgG may function as a possible signature of chronic antigenic responses and inflammation, associated with comorbidities that increase COVID-19 hospitalization. Evaluating total IgM and IgG as prognostic biomarkers in COVID-19 pneumonia patients may contribute to improved management and clinical outcomes.
- 1 May 2023
- Vol. 53 (3) , 341-352
Serum Immunoglobulin Levels as Potential Biomarkers of COVID-19 Pneumonia
Objective. Severe Acute Respiratory Coronavirus-2 (SARS-CoV-2) has been known to cause immune dysregulation. However, the association between specific immunoglobulins and clinical characteristics in COVID-19 remains poorly understood. This study investigated the relationship between immunoglobulins and clinical outcomes in adults hospitalized with COVID-19 pneumonia. Methods. A retrospective chart analysis was performed (N=569, December 2020-April 2021). Information on demographics, clinical factors, and total serum immunoglobulin (IgG, IgA, IgM, and IgE) levels were collected (N=60). Clinical outcomes of interest included: symptom duration, comorbidities (Charlson 10-year-estimated-survival (C10YES) and comorbidity index (CCI), vital derangements upon presentation (NEWS-2-score), length of stay (LOS), and mortality. Spearman correlation, chi-square tests and linear regression were conducted. Results. Serum IgM levels were positive predictors of C10YES (beta=0.104, p=0.023) and negative predictors of CCI (beta=-0.007, p=0.047). There was an association between higher serum IgG levels and longer LoS (beta=7.455, p=0.047). We found no significant associations between immunoglobulins and pre-admission symptom duration, medication use, or mortality. Conclusions. Total IgM was associated with increased survival and decreased comorbidity, and total IgG was associated with length of hospitalization. IgM may predict the body's initial ability to produce humoral immune responses, and IgG may function as a possible signature of chronic antigenic responses and inflammation, associated with comorbidities that increase COVID-19 hospitalization. Evaluating total IgM and IgG as prognostic biomarkers in COVID-19 pneumonia patients may contribute to improved management and clinical outcomes.
- 29 October 2022
- Published by Springer Nature
- p. 107-112
Allergic Bronchopulmonary Aspergillosis
- 1 July 2022
- Vol. 52 (4) , 686-687
Levels of Salivary Melatonin (AM and PM) in Adults with Allergic Respiratory Disease: Part II
- 1 July 2022
- Vol. 52 (4) , 686-687
Levels of Salivary Melatonin (AM and PM) in Adults with Allergic Respiratory Disease: Part II
- 1 May 2022
- Vol. 52 (3) , 507-509
Letter to the Editor: Levels of Salivary Melatonin (AM and PM) in Adults with Allergic Respiratory Disease
- 1 May 2022
- Vol. 52 (3) , 507-509
Letter to the Editor: Levels of Salivary Melatonin (AM and PM) in Adults with Allergic Respiratory Disease
- 1 June 2018
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 24 (6) , 470-475
Doxycycline suppresses Chlamydia pneumoniae induced interferon-gamma responses in peripheral blood mononuclear cells in children with allergic asthma
- 1 June 2018
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 24 (6) , 470-475
Doxycycline suppresses Chlamydia pneumoniae induced interferon-gamma responses in peripheral blood mononuclear cells in children with allergic asthma
- 1 December 2016
- Published by Elsevier in Clinics In Laboratory Medicine
- Vol. 36 (4) , 795-801
Clinical Toxicology and Its Relevance to Asthma and Atopy
- 1 December 2016
- Published by Elsevier in Clinics In Laboratory Medicine
- Vol. 36 (4) , 795-801
Clinical Toxicology and Its Relevance to Asthma and Atopy
- Open Access
- 1 January 2015
- Published by SAGE Publications in Allergy & Rhinology
- Vol. 6 (1) , E39-E43
A Retrospective Study of Peanut and Tree Nut Allergy: Sensitization and Correlations with Clinical Manifestations
Peanut (PN) and tree nut (TN) allergies are among the leading causes of fatal food-induced anaphylaxis and are increasing in prevalence, especially in children. Their cosensitization and concurrent clinical allergy have been understudied. This retrospective study investigated the correlation between PN and TN allergy, both in terms of in vitro sensitization (IVS) and clinical allergic manifestations. We conducted a retrospective medical record review at the Allergy Clinic at University Hospital of Brooklyn. Fourteen hundred six charts were reviewed, of which 76 (5.4%) had documented relevant clinical allergy: PN allergy but not TN allergy (n = 29) or TN allergy but not PN allergy (n = 11) or both (n = 30). Six patients with PN allergy but no TN exposure history were not included in the analysis. The majority of patients (67/76, 88.1%) had a concurrent history of asthma, rhinoconjunctivitis, or AD. Sensitivity of TN IVS predicting PN IVS was 38/39 (97%). Similarly, sensitivity of PN IVS predicting TN IVS was 38/42 (91%). Sensitivity of TN clinical allergy predicting PN allergy was 30/59 (51%). Sensitivity of PN clinical allergy predicting TN allergy was 30/41 (73%). The total number of organ systems involved in reported clinical reactions correlated with IVS to TN (p = 0.004) but not IVS to PN (p = 0.983). In summary, we found PN sensitization predicts TN sensitization in vitro, with lower predictability for clinical reactions.
- 1 January 2015
- Published by SAGE Publications in Allergy & Rhinology
- Vol. 6 (1) , E39-E43
Open AccessA Retrospective Study of Peanut and Tree Nut Allergy: Sensitization and Correlations with Clinical Manifestations
Peanut (PN) and tree nut (TN) allergies are among the leading causes of fatal food-induced anaphylaxis and are increasing in prevalence, especially in children. Their cosensitization and concurrent clinical allergy have been understudied. This retrospective study investigated the correlation between PN and TN allergy, both in terms of in vitro sensitization (IVS) and clinical allergic manifestations. We conducted a retrospective medical record review at the Allergy Clinic at University Hospital of Brooklyn. Fourteen hundred six charts were reviewed, of which 76 (5.4%) had documented relevant clinical allergy: PN allergy but not TN allergy (n = 29) or TN allergy but not PN allergy (n = 11) or both (n = 30). Six patients with PN allergy but no TN exposure history were not included in the analysis. The majority of patients (67/76, 88.1%) had a concurrent history of asthma, rhinoconjunctivitis, or AD. Sensitivity of TN IVS predicting PN IVS was 38/39 (97%). Similarly, sensitivity of PN IVS predicting TN IVS was 38/42 (91%). Sensitivity of TN clinical allergy predicting PN allergy was 30/59 (51%). Sensitivity of PN clinical allergy predicting TN allergy was 30/41 (73%). The total number of organ systems involved in reported clinical reactions correlated with IVS to TN (p = 0.004) but not IVS to PN (p = 0.983). In summary, we found PN sensitization predicts TN sensitization in vitro, with lower predictability for clinical reactions.